MedPath

安徽墨药制药股份有限公司

Ownership
-
Established
2006-03-28
Employees
-
Market Cap
-
Website
http://www.anhuimoyao.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

5

NMPA:5

Drug Approvals

八宝五胆药墨

Approval Number
国药准字Z34020249
Approval Date
Jan 22, 2021
NMPA

Chloroquine Phosphate Tablets

Product Name
磷酸氯喹片
Approval Number
国药准字H34022661
Approval Date
Sep 24, 2020
NMPA

八宝五胆药墨

Approval Number
国药准字Z34020248
Approval Date
Aug 7, 2020
NMPA

八宝五胆药墨

Approval Number
国药准字Z34020247
Approval Date
Aug 7, 2020
NMPA

Potassium Permanganate

Product Name
高锰酸钾
Approval Number
国药准字H22026515
Approval Date
Mar 5, 2020
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.